0001209191-23-009873.txt : 20230215
0001209191-23-009873.hdr.sgml : 20230215
20230215183244
ACCESSION NUMBER: 0001209191-23-009873
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230213
FILED AS OF DATE: 20230215
DATE AS OF CHANGE: 20230215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SEIDENBERG BETH C
CENTRAL INDEX KEY: 0001184592
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40407
FILM NUMBER: 23636681
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001831828
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 812744449
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8000 MARINA BOULEVARD, SUITE 120
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 650-770-0077
MAIL ADDRESS:
STREET 1: 8000 MARINA BOULEVARD, SUITE 120
CITY: BRISBANE
STATE: CA
ZIP: 94005
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-13
0
0001831828
Vera Therapeutics, Inc.
VERA
0001184592
SEIDENBERG BETH C
C/O VERA THERAPEUTICS, INC.
8000 MARINA BOULEVARD, SUITE 120
BRISBANE
CA
94005
1
0
0
0
Class A Common Stock
2023-02-13
4
P
0
10072
7.1972
A
1664702
I
See footnote
The shares were purchased as follows: 9,739 shares by Kleiner Perkins Caufield & Byers XVI, LLC ("KPCB XVI") and 333 shares by KPCB XVI Founders Fund, LLC ("XVI Founders"). All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XVI and XVI Founders is KPCB XVI Associates, LLC ("XVI Associates"). L. John Doerr, Beth Seidenberg, Randy Komisar, Theodore E. Schlein and Wen Hsieh, the managing members of XVI Associates, exercise shared voting and dispositive control over the shares held by KPCB XVI and XVI Founders. Such managing members disclaim beneficial ownership of all shares held by KPCB XVI and XVI Founders except to the extent of their pecuniary interest therein.
Represents weighted average purchase price. The shares were purchased at prices ranging from $7.1096 to $7.2500. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Consists of 1,609,603 shares of Class A Common Stock held by KPCB XVI and 55,099 shares of Class A Common Stock held by XVI Founders.
/s/ Joseph R. Young, Attorney-in-Fact
2023-02-15